Targeted Cancer Therapies Market Analysis by Disease Indication (Gastrointestinal, Lung Cancer, Breast Cancer), by End User (Hospitals), by Therapy Type (Hormone Therapies, Signal Transduction Inhibitors, Gene Expression Modulators), and by Region - Global Forecast to 2022-2033

The targeted cancer therapies market size is estimated to be USD 69,570 million in 2022 and is expected to witness a CAGR of 5.48% during the forecast period 2023-2033. The rising rates of malignancies, including gastrointestinal, colorectal, lung, and breast cancer, among others, expanding patient aid initiatives (PAPs), expanding government programs to raise awareness of cancer, increasing global cancer prevalence, and substantial R&D efforts from important players are factors contributing to the market growth. However, greater prices for these treatments and genetic diagnostic tests that identify cancer is expected to hinder the growth.

Segmentation

By Disease Indication

Based on disease indication, the market is segregated into gastrointestinal, lung cancer, breast, cancer, colorectal cancer, leukemia, lymphoma, melanoma, prostate cancer, and others. In 2022, the breast cancer segment held the highest market share owing to the strong trend of continual R&D among leading market companies involved in breast cancer therapies will result in the release of game-changing medicines in the future years and increasing demand for precise and effective treatment outcomes for the patient remains unmatched as more and more people across the world are receiving breast cancer diagnoses.

By End User

On the basis of end user, the market is categorized into hospitals, cancer and radiation therapy centers, and clinics. In 2022, the cancer and radiation therapy centers segment held the highest market share due to increasing the number of patients who choose less invasive outpatient operations that can be done in the doctor’s office rather than inpatient procedures that could need anaesthesia.

By Therapy Type

Based on therapy type, the market is divided into hormone therapies, signal transduction inhibitors, gene expression modulators, apoptosis inducers, angiogenesis inhibitors, immunotherapies, and monoclonal antibodies. In 2022, the monoclonal antibodies segment held the highest market share owing to its benefits that it fights cancer by a number of techniques, including activating host immune functions to attack the target cell, attaching to ligands or receptors, and disrupting key cancer cell activities, and transporting a fatal payload to the target cell, such as a radioisotope or toxin.

Regional Markets

In 2022, North America region accounted for the highest revenue in the targeted cancer therapies market and is expected to maintain its dominance during the forecast period. This is attributed to the increased activity in mergers and acquisitions, rising technological advancements, increasing health insurance coverage, a rise in foreign direct investment, increasing elderly population, drastically altering lives, increased competition, and more widespread cancer insurance coverage. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to the rising consciousness, increasing cancer cases, and increasing government investment and demand.

Competitor Insights

Some of the key players operating in the targeted cancer therapies market are Sanofi (France), Pfizer, Inc (US). OncoGenex Pharmaceuticals Inc. (US), GlaxoSmithKline plc (UK), CYTOKINETICS INC. (US), Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), AVEO Pharmaceuticals Inc. (US), AstraZeneca PLC (UK), and Abbott Laboratories (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including disease indication, end user, and therapy type from 2023 to 2033.

Report Scope:

Key Parameters Details
Market size in 2022
  • USD 69,570 Million
CAGR
  • 5.48%
Base Year
  • 2022
Forecast Period
  • 2023-2033
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • COVID-19 impact analysis
Segment Market Scope
  • Disease Indication
  • End User
  • Therapy Type
Regional Market Scope
  • North America
    (U.S. and Canada)
  • Europe
    (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific
    (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America
    (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA
    (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • Other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Segmentation: Targeted Cancer Therapies Market Report 2022 – 2033

Disease Indication (Revenue, USD Million), 2022 – 2033

  • Gastrointestinal
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Leukemia
  • Lymphoma
  • Melanoma
  • Prostate Cancer
  • Others

End User (Revenue, USD Million), 2022 – 2033

  • Hospitals
  • Cancer and Radiation Therapy Centers
  • Clinics

Therapy Type (Revenue, USD Million), 2022 – 2033

  • Hormone Therapies
  • Signal Transduction Inhibitors
  • Gene Expression Modulators
  • Apoptosis Inducers
  • Angiogenesis Inhibitors
  • Immunotherapies
  • Monoclonal Antibodies

By Region (Revenue, USD Million), 2022 – 2033

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Table of Contents: Targeted Cancer Therapies Market 2022-2033

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
  1. Introduction: Targeted Cancer Therapies
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. SWOT Analysis
  2. COVID-19 Impact Analysis: Targeted Cancer Therapies Market
  3. Market Analysis by Disease Indication
    1. Gastrointestinal
      1. Gastrointestinal Market Forecast, 2022-2033(USD Million)
    2. Lung Cancer
      1. Lung Cancer Market Forecast, 2022-2033(USD Million)
    3. Breast Cancer
      1. Breast Cancer Market Forecast, 2022-2033(USD Million))
    4. Colorectal Cancer
      1. Colorectal Cancer Market Forecast, 2022-2033(USD Million)
    5. Leukemia
      1. Leukemia Market Forecast, 2022-2033(USD Million)
    6. Lymphoma
      1. Lymphoma Market Forecast, 2022-2033(USD Million)
    7. Melanoma
      1. Melanoma Market Forecast, 2022-2033 (USD Million)(USD Million)
    8. Prostate Cancer
      1. Prostate Cancer Market Forecast, 2022-2033 (USD Million)(USD Million)
    9. Others
      1. Others Market Forecast, 2022-2033 (USD Million)(USD Million)
  1. Market Analysis by End User
    1. Hospitals
      1. Hospitals Market Forecast, 2022-2033 (USD Million)(USD Million)
    2. Cancer and Radiation Therapy Centers
      1. Cancer and Radiation Therapy Centers Market Forecast, 2022-2033 (USD Million)(USD Million)
    3. Clinics
      1. Clinics Market Forecast, 2022-2033 (USD Million)(USD Million)
  1. Market Analysis by Therapy Type
    1. Hormone Therapies
      1. Hormone TherapiesMarket Forecast, 2022-2033 (USD Million)(USD Million)
    2. Signal Transduction Inhibitors
      1. Signal Transduction Inhibitors Market Forecast, 2022-2033 (USD Million)(USD Million)
    3. Gene Expression Modulators
      1. Gene Expression Modulators Market Forecast, 2022-2033 (USD Million)(USD Million)
    4. Apoptosis Inducers
      1. Apoptosis Inducers Market Forecast, 2022-2033 (USD Million)(USD Million)
    5. Angiogenesis Inhibitors
      1. Angiogenesis Inhibitors Market Forecast, 2022-2033 (USD Million)(USD Million)
    6. Immunotherapies
      1. Immunotherapies Market Forecast, 2022-2033 (USD Million)(USD Million)
    7. Monoclonal Antibodies
      1. Monoclonal Antibodies Market Forecast, 2022-2033 (USD Million)(USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends Analysis
  2. North America Targeted Cancer Therapies Market
    1. North America Targeted Cancer Therapies Market
      1. North America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
        3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
      2. S. Targeted Cancer Therapies Market
        1. S. Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
          3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Canada Targeted Cancer Therapies Market
          1. Canada Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
            3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
  1. Europe Targeted Cancer Therapies Market
    1. Europe Targeted Cancer Therapies Market
      1. Europe Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
        3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
      2. Germany Targeted Cancer Therapies Market
        1. Germany Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
          3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. UK Targeted Cancer Therapies Market
          1. UK Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
            3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. France Targeted Cancer Therapies Market
            1. France Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
              3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Spain Targeted Cancer Therapies Market
              1. Spain Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
                3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Italy Targeted Cancer Therapies Market
                1. Italy Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                  3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                2. Rest of Europe Targeted Cancer Therapies Market
                  1. Rest of Europe Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
                    3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
  1. Asia Pacific Targeted Cancer Therapies Market
    1. Asia Pacific Targeted Cancer Therapies Market
      1. Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
        3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
      2. Japan Targeted Cancer Therapies Market
        1. Japan Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
          3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. China Targeted Cancer Therapies Market
          1. China Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
            3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. India Targeted Cancer Therapies Market
            1. India Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
              3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. South Korea Targeted Cancer Therapies Market
              1. South Korea Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
                3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
              2. Australia Targeted Cancer Therapies Market
                1. Australia Market Size and Forecast, 2022-2033(USD Million)
                  1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                  2. Market Size and Forecast by End User, 2022-2033(USD Million)
                  3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
                2. Rest of Asia Pacific Targeted Cancer Therapies Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2022-2033(USD Million)
                    1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                    2. Market Size and Forecast by End User, 2022-2033(USD Million)
                    3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
  1. Latin America Targeted Cancer Therapies Market
    1. Latin America Targeted Cancer Therapies Market
      1. Latin America Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
        3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
      2. Brazil Targeted Cancer Therapies Market
        1. Brazil Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
          3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. Mexico Targeted Cancer Therapies Market
          1. Mexico Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
            3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Argentina Targeted Cancer Therapies Market
            1. Argentina Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
              3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
            2. Rest of Latin America Targeted Cancer Therapies Market
              1. Rest of Latin America Market Size and Forecast, 2022-2033(USD Million)
                1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
                2. Market Size and Forecast by End User, 2022-2033(USD Million)
                3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
  1. MEA Targeted Cancer Therapies Market
    1. MEA Targeted Cancer Therapies Market
      1. MEA Market Size and Forecast, 2022-2033(USD Million)
        1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
        2. Market Size and Forecast by End User, 2022-2033(USD Million)
        3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
      2. GCC Targeted Cancer Therapies Market
        1. GCC Market Size and Forecast, 2022-2033(USD Million)
          1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
          2. Market Size and Forecast by End User, 2022-2033(USD Million)
          3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
        2. South Africa Targeted Cancer Therapies Market
          1. South Africa Market Size and Forecast, 2022-2033(USD Million)
            1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
            2. Market Size and Forecast by End User, 2022-2033(USD Million)
            3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
          2. Rest of MEA Targeted Cancer Therapies Market
            1. Rest of MEA Market Size and Forecast, 2022-2033(USD Million)
              1. Market Size and Forecast by Disease Indication, 2022-2033(USD Million)
              2. Market Size and Forecast by End User, 2022-2033(USD Million)
              3. Market Size and Forecast by Therapy Type, 2022-2033(USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2022
    2. Major Recent Developments, 2019-2022
  2. Company Profiles
    1. Sanofi (France)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Pfizer, Inc (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. OncoGenex Pharmaceuticals Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. GlaxoSmithKline plc (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. CYTOKINETICS INC. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. Boehringer Ingelheim GmbH (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Bayer AG (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. AVEO Pharmaceuticals Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. AstraZeneca PLC (UK)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. Abbott Laboratories (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Company 11
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. Company 12
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Company 13
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Company 14
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. Company 15
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion
  4. Recommendations

Leave a comment

Your email address will not be published. Required fields are marked *

Select License Type

5 reasons to choose Quintana Research Reports

Our top-quality, real-time, accurate, and data-driven research aims at empowering the clients with actionable insights.

We deliver timely data-driven insights to help clients make informed decisions and achieve growth and success.

Our team of experts is available 24*7 to offer incisive analysis of the market for clients.

We offer comprehensive and bespoke marketing research as per clients’ requirements.

Our cost-effective and rapid research helps clients gain competitive intelligence, and uncover potential opportunities & threats.